Dilated Cardiomyopathy: From Genetics to Clinical Management
Open accessThe DOI matches its Crossref record; 605 of the 607 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
This open access book presents a multidisciplinary comprehensive overview of dilated cardiomyopathy, from pathophysiology, differential diagnosis work-up, to clinical management. It further highlights open issues such as the clinical use of genetic testing and arrhythmia in dilated cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–600 of 607
Schalla, S. M., Bekkers, S. C. A. M., Dennert, R. M., van Suylen, R. J., Waltenberger, J. L., Leiner, T., Wildberger, J. E., Crijns, H. J. G. M., & Heymans, S. R. B. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq004 · Cited by 82
(2000) · Time to knit · doi:10.1016/j.ymed.2016.08.094 · Cited by 82
Zecchin, M., Merlo, M., Pivetta, A., Barbati, G., Lutman, C., Gregori, D., Serdoz, L. V., Bardari, S., Magnani, S., Lenarda, A. D., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.033 · Cited by 80
Self-citationBoeck, B. W. L. D., Meine, M., Leenders, G. E. H., Teske, A. J., van Wessel, H., Kirkels, J. H., Prinzen, F. W., Doevendans, P. A., & Cramer, M. J. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.02.003 · Cited by 79
Diagnosis, prevalence, and screening of familial dilated cardiomyopathy
Sweet, M., Taylor, M. R. G., & Mestroni, L. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1057498 · Cited by 78
Incidence of congestive cardiomyopathy
Torp, A. (1978) · Postgraduate Medical Journal · doi:10.1136/pgmj.54.633.435 · Cited by 78
Marsan, N. A., Bleeker, G. B., Ypenburg, C., van Bommel, R. J., Ghio, S., de Veire, N. R. V., Delgado, V., Holman, E. R., van der Wall, E. E., Schalij, M. J., et al. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.05.021 · Cited by 78
Casolo, G., Minneci, S., Manta, R., Sulla, A., Meglio, J. D., Rega, L., & Gensini, G. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.03.068 · Cited by 78 · cited 1×
“In patients presenting with de novo acute heart failure (HF) and no clinical or electrocardiographic suggestion of ischemic etiology, LGE-CMR is sensitive and specific for the presence of underlying significant coronary artery disease (CAD) [11, 12].”
Psaltis, P. J., Carbone, A., Nelson, A. J., Lau, D. H., Jantzen, T., Manavis, J., Williams, K., Itescu, S., Sanders, P., Gronthos, S., et al. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.05.016 · Cited by 78
Changing mortality in dilated cardiomyopathy
Di Lenarda, A., Secoli, G., Perkan, A., Gregori, D., Lardieri, G., Pinamonti, B., Sinagra, G., Zecchin, M., Camerini, F., & Heart Muscle Disease Study Group (1994) · Heart · doi:10.1136/hrt.72.6_suppl.s46 · Cited by 77
Self-citationKawahara, C., Tsutamoto, T., Nishiyama, K., Yamaji, M., Sakai, H., Fujii, M., Yamamoto, T., & Horie, M. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0837 · Cited by 77
Prazak, P., Pfisterer, M. E., Osswald, S., Buser, P., & Burkart, F. E. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014842 · Cited by 74 · cited 1×
“The natural history of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy has been a highly controversial issue [38, 39].”
BackgroundThe role of echocardiography in guiding management in dilated cardiomyopathy
Thomas, D. E., Wheeler, R., Yousef, Z. R., & Masani, N. D. (2009) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep158 · Cited by 74
Martino, H. F., Brofman, P. R. S., Greco, O. T., Bueno, R. L., Bodanese, L. C., Clausell, N., Maldonado, J. G. A., Mill, J. G., Braile, D. M., Moraes, J. B. D. M. X., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv477 · Cited by 74
McCrohon, J. A., Moon, J., & Prasad, S. (2003) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.09.030 · Cited by 74
Natural History of Dilated Cardiomyopathy in Children
Puggia, I., Merlo, M., Barbati, G., Rowland, T. J., Stolfo, D., Gigli, M., Ramani, F., Lenarda, A. D., Mestroni, L., & Sinagra, G. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003450 · Cited by 73
Self-citationBaeßler, B., Schaarschmidt, F., Stehning, C., Schnackenburg, B., Maintz, D. C., & Bunck, A. C. (2015) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-015-0177-2 · Cited by 72
Left ventricular versus biventricular dysfunction in idiopathic dilated cardiomyopathy
Vecchia, L. L., Paccanaro, M., Bonanno, C., Varotto, L., OMETTO, R., & Vincenzi, M. D. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00795-4 · Cited by 72 · cited 1×
“Biventricular involvement in DCM identifies a subset of patients with poor outcome [107, 108].”
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
Ware, J. S., Seidman, J. G., & Arany, Z. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1602671 · Cited by 72
Giant Cell Myocarditis as a Manifestation of Drug Hypersensitivity
Daniels, P. R., Berry, G. J., Tazelaar, H. D., & Cooper, L. T. (2000) · Cardiovascular Pathology · doi:10.1016/s1054-8807(00)00049-1 · Cited by 71 · cited 1×
“The hallmark histological findings of HSM include an interstitial infiltrate with prominent eosinophils with little myocyte necrosis; however, granulomatous myocarditis, or necrotizing eosinophilic myocarditis, may also be a manifestation of drug hypersensitivity [21] and may be distinguished from common forms of HSM…”
BackgroundSen-Chowdhry, S., Syrris, P., Pantazis, A., Quarta, G., McKenna, W. J., & Chambers, J. C. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.109.935262 · Cited by 71
Soliman, O. I. I., Geleijnse, M. L., Theuns, D. A. M. J., van Dalen, B. M., Vletter, W. B., Jordaens, L. J. L. M., Metawei, A. K., Al-Amin, A. M., & ten Cate, F. J. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.372 · Cited by 71
Aleksova, A., Carriere, C., Zecchin, M., Barbati, G., Vitrella, G., Lenarda, A. D., & Sinagra, G. (2014) · EP Europace · doi:10.1093/europace/euu016 · Cited by 71
Self-citationPoor Prognosis of Rare Sarcomeric Gene Variants in Patients with Dilated Cardiomyopathy
Merlo, M., Sinagra, G., Carniel, E., Slavov, D. B., Zhu, X., Barbati, G., Spezzacatene, A., Ramani, F., Salcedo, E. E., Lenarda, A. D., et al. (2013) · Clinical and Translational Science · doi:10.1111/cts.12116 · Cited by 70
Self-citationHenry, T. D., Traverse, J. H., Hammon, B. L., East, C. A., Bruckner, B., Remmers, A. E., Recker, D., Bull, D. A., & Patel, A. N. (2014) · Circulation Research · doi:10.1161/circresaha.115.304554 · Cited by 70
Myocardial biopsy: A useful diagnostic procedure or only a research tool?
Ferrans, V. J., & Roberts, W. C. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90741-5 · Cited by 69 · cited 1×
“Ferrans and Roberts [2], as early as 1978, concluded that in patients with suspected dilated cardiomyopathy (DCM), the technique is “informative” but of limited “diagnostic value”.”
BackgroundKETTERING, K., MEWIS, C., DÖRNBERGER, V., VONTHEIN, R., BOSCH, R. F., & KÜHLKAMP, V. (2002) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2002.01571.x · Cited by 69
Meluzı́n, J., Špinarová, L., Hude, P., Krejčí, J., Poloczková, H., Podroužková, H., Pešl, M., Orban, M., Dušek, L., & Korinek, J. K. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2009.02.022 · Cited by 68
D’Andrea, A., Caso, P., Scarafile, R., Riegler, L., Salerno, G., Castaldo, F., Gravino, R., Cocchia, R., Viscovo, L. D., Limongelli, G., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn010 · Cited by 68
Marjamaa, A., Laitinen‐Forsblom, P., Lahtinen, A. M., Viitasalo, M., Toivonen, L., Kontula, K., & Swan, H. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-12 · Cited by 68 · cited 2×
“One of the best characterized mutations is Arg222Gln [20], which affects the VSD.”
BackgroundBrembilla-Perrot, B., Ferreira, J. P., Manenti, V., Sellal, J., Olivier, A., Villemin, T., Beurrier, D., de Chillou, C., Louis, P., Brembilla, A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.482 · Cited by 68
Mechanisms and management of the heart in myotonic dystrophy
McNally, E. M., & Sparano, D. (2011) · Heart · doi:10.1136/hrt.2010.214197 · Cited by 67
Faris, R. F., Coats, A. J. S., & Henein, M. Y. (2002) · American Heart Journal · doi:10.1067/mhj.2002.123844 · Cited by 67
Bunch, T. J., May, H. T., Bair, T. L., Jacobs, V., Crandall, B. G., Cutler, M. J., Weiss, J. P., Mallender, C. D., Osborn, J. S., Anderson, J. L., et al. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12602 · Cited by 67
Stolfo, D., Merlo, M., Pinamonti, B., Poli, S., Gigli, M., Barbati, G., Fabris, E., Lenarda, A. D., & Sinagra, G. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.549 · Cited by 66
Self-citationPrognostic Impact of Familial Screening in Dilated Cardiomyopathy
Moretti, M., Merlo, M., Barbati, G., Di Lenarda, A., Brun, F., Pinamonti, B., Gregori, D., Mestroni, L., & Sinagra, G. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq093 · Cited by 65
Self-citationGao, D., Van Herendael, H., Alshengeiti, L., Dorian, P., Mangat, I., Korley, V., Ahmad, K., Golovchiner, G., Aves, T., & Pinter, A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31829651fe · Cited by 64
Pelliccia, A., Fagard, R. H., & Bjøornstad, H. H. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.10.013 · Cited by 64
Wheeler, D. C., London, G. M., Goodman, W. G., Moe, S. M., Trotman, M.-L., Abdalla, S. I. A., Chertow, G. M., Herzog, C. A., Therapy, E. C. H., Parfrey, P. S., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.000570 · Cited by 64
Heart failure in systemic lupus erythematosus
Dhakal, B. P., Kim, C. H., Al-Kindi, S. G., & Oliveira, G. H. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.08.015 · Cited by 64
Gordon, C., Amissah-Arthur, M.-B., Gayed, M., Brown, S., Bruce, I. N., D’Cruz, D. P., Empson, B., Griffiths, B., Jayne, D. R. W., Khamashta, M. A., et al. (2017) · Rheumatology · doi:10.1093/rheumatology/kex291 · Cited by 64
Influence of Pacing Site Characteristics on Response to Cardiac Resynchronization Therapy
Wong, J. A., Yee, R. K., Stirrat, J., Scholl, D., Krahn, A. D., Gula, L. J., Skanes, A. C., Leong‐Sit, P., Klein, G. J., McCarty, D., et al. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.111.000146 · Cited by 63
THE EPIDEMIOLOGY OF IDIOPATHIC DILATED CARDIOMYOPATHY IN A BIRACIAL COMMUNITY
Coughlin, S. S., Szklo, M., Baughman, K. L., & Pearson, T. A. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115484 · Cited by 63
Walsh, R., Thomson, K. L., Ware, J. S., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/041111 · Cited by 61
Biomarkers in Acute Heart Failure
Mallick, A., & Januzzi, J. L. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.02.009 · Cited by 60
Friedberg, M. K., & Slorach, C. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.03.064 · Cited by 60
A Randomized Trial of the Angiotensin‐Receptor Blocker Valsartan in Chronic Heart Failure
Tepper, D. (2002) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00752.x · Cited by 59 · cited 1×
“ACEi [29, 32, 33], ARB [34, 35], beta-blocker [36–38], and MRA [39, 40] have demonstrated, in several clinical trials, to reduce risk of HF hospitalization and death in patient with HF and reduced EF.”
Arya, A., Bode, K., Piorkowski, C., Bollmann, A., Sommer, P., Gaspar, T., Wetzel, U., Husser, D., Kottkamp, H., & Hindricks, G. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02835.x · Cited by 59
Modern Imaging Techniques in Cardiomyopathies
Jan, M. F., & Tajik, A. J. (2017) · Circulation Research · doi:10.1161/circresaha.117.309600 · Cited by 58
Long-term outcome of 'super-responder' patients to cardiac resynchronization therapy
Zecchin, M., Proclemer, A., Magnani, S., Serdoz, L. V., Facchin, D., Muser, D., Nordio, A., Barbati, G., Puggia, I., Sinagra, G., et al. (2013) · EP Europace · doi:10.1093/europace/eut339 · Cited by 58
Self-citationAtrial Dimensions in Health and Left Ventricular Disease Using Cardiovascular Magnetic Resonance
Anderson, J. L., Horne, B. D., & Pennell, D. J. (2005) · Journal of Cardiovascular Magnetic Resonance · doi:10.1081/jcmr-200065617 · Cited by 58
Berardini, A., Biagini, E., Saia, F., Stolfo, D., Previtali, M., Grigioni, F., Pinamonti, B., Crimi, G., Salvi, A., Ferrario, M., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.241 · Cited by 57
Self-citationDilated cardiomyopathy and thrombo-embolism
Günthard, J., Stocker, F., Bolz, D., JAEGGI, E. T., Ghisla, R., Oberhänsli, I., & Wyler, F. (1996) · European Journal of Pediatrics · doi:10.1007/s004310050541 · Cited by 55
Insights into Mildly Dilated Cardiomyopathy: Temporal Evolution and Long-Term Prognosis
Gigli, M., Stolfo, D., Merlo, M., Barbati, G., Ramani, F., Brun, F., Pinamonti, B., & Sinagra, G. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.608 · Cited by 55
Self-citationHeart failure biomarkers in patients with dilated cardiomyopathy
Bielecka-Dabrowa, A. M., von Haehling, S., Aronow, W. S., Ahmed, M. I., Rysz, J., & Banach, M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.157 · Cited by 54
Morani, G., Gasparini, M., Zanon, F., Casali, E., Spotti, A., Reggiani, A., Bertaglia, E., Solimene, F., Molon, G., Accogli, M., et al. (2013) · EP Europace · doi:10.1093/europace/eut032 · Cited by 54
Determinants of prognosis in nonischemic dilated cardiomyopathy
Grzybowski, J., Bilińska, Z. T., Rużyłło, W., Kupść, W., Michalak, E., Szcześniewska, D., Popławska, W., & Rydlewska-Sadowska, W. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80026-1 · Cited by 53 · cited 1×
“LV ejection fraction (LVEF) is the strongest predictor of progression to HF [32], while LV volume and mass are independently correlated with mortality and morbidity.”
Kleijn, S. A., van Dijk, J., de Cock, C. C., Allaart, C. P., van Rossum, A. C., & Kamp, O. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2009.06.012 · Cited by 53
Gravlee, G. P. (2008) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(08)70835-0 · Cited by 53
Cardiac Sarcoidosis: Clinical Manifestations, Imaging Characteristics, and Therapeutic Approach
Houston, B. A., & Mukherjee, M. (2014) · Clinical Medicine Insights: Cardiology · doi:10.4137/cmc.s15713 · Cited by 52
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy
Brun, F., Barnes, C., Sinagra, G., Slavov, D. B., Barbati, G., Zhu, X., Graw, S. L., Spezzacatene, A., Pinamonti, B., Merlo, M., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102591 · Cited by 51
Self-citationValle-Munoz, A., Estornell-Erill, J., Soriano-Navarro, C. J., Nadal-Barange, M., Martinez-Alzamora, N., Pomar-Domingo, F., Corbi-Pascual, M., Paya-Serrano, R., & Ridocci-Soriano, F. (2009) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep115 · Cited by 51 · cited 1×
“In patients presenting with de novo acute heart failure (HF) and no clinical or electrocardiographic suggestion of ischemic etiology, LGE-CMR is sensitive and specific for the presence of underlying significant coronary artery disease (CAD) [11, 12].”
Aleksova, A., Sabbadini, G., Merlo, M., Pinamonti, B., Barbati, G., Zecchin, M., Bussani, R., Silvestri, F., Iorio, A. M., Stolfo, D., et al. (2009) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32832bba35 · Cited by 50 · cited 1×
“Identifying patients with DCM in an asymptomatic phase is equivalent to early diagnosis and guarantees a better longterm survival for the patients [14].”
Self-citationJasaitytė, R., Dandel, M., Lehmkuhl, H. B., & Hetzer, R. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.10.083 · Cited by 50
Myocardial biopsy: techniques and indications
Francis, R., & Lewis, C. J. (2017) · Heart · doi:10.1136/heartjnl-2017-311382 · Cited by 50
Bansch, D., Antz, M., & Boczor, S. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00817-6 · Cited by 50
ZECCHIN, M., DI LENARDA, A., GREGORI, D., MERLO, M., PIVETTA, A., VITRELLA, G., SABBADINI, G., MESTRONI, L., & SINAGRA, G. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.00988.x · Cited by 49 · cited 1×
“In a non-genotyped cohort of individuals with NSVT and DCM, the number and length of NSVT runs is predictive of major ventricular arrhythmias only in cases where LVEF exceeds 35%.(73) Compelling data do not support, and guidelines do not advise, the use of genetic testing for SCD risk stratification in patients with D…”
Self-citationMatsumura, Y., Hoshikawa, E., Kubo, T., Yamasaki, N., Furuno, T., Kitaoka, H., Takata, J., Sugiura, T., & Doi, Y. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.056 · Cited by 49
Pinamonti, B., Perkan, A., Lenarda, A. D., Gregori, D., & Sinagra, G. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00208-2 · Cited by 49
Self-citationIsolation of Borrelia burgdorferi from myocardium
Lardieri, G., Salvi, A., Camerini, F., Cinco, M., & Trevisan, G. (1993) · The Lancet · doi:10.1016/0140-6736(93)91612-p · Cited by 48 · cited 1×
“Cardiac function returned to normal following treatment with penicillin, in addition to standard heart failure therapy [16].”
BackgroundIkeda, Y., Inomata, T., Fujita, T., Iida, Y., Nabeta, T., Ishii, S., Maekawa, E., Yanagisawa, T., Mizutani, T., Naruke, T., et al. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0805-2 · Cited by 48
Dilated Cardiomyopathy Overview
Hershberger, R. E., & Morales, A. (2015) · Europe PMC (PubMed Central) · Cited by 48
Takamura, T., Dohi, K., Onishi, K., Tanabe, M., Sugiura, E., Nakajima, H., Ichikawa, K., Nakamura, M., Nobori, T., & Ito, M. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.04.005 · Cited by 47
Imaging Challenges in Secondary Mitral Regurgitation: Unsolved Issues and Perspectives
Lancellotti, P., Zamorano, J. L., & Vannan, M. A. (2014) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.114.000992 · Cited by 46
Harnessing the microRNA pathway for cardiac regeneration
Giacca, M., & Zacchigna, S. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.09.017 · Cited by 45
Crispell, K. A., Hanson, E. L., Coates, K., Toy, W., & Hershberger, R. E. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01788-6 · Cited by 45 · cited 1×
“In addition to family history, periodic screening, consisting of physical examination and instrumental evaluation (ECG and echocardiogram), can mark the transition to the phenotypic expression of the disease, even when the relative is yet asymptomatic [4, 6].”
Guidelines for autopsy investigation of sudden cardiac death.
Basso, C., Burke, M. M., Fornés, P., Gallagher, P. J., de Gouveia, R. H., Sheppard, M. N., Thiene, G., & van der Wal, A. C. (2010) · PubMed · Cited by 45
Cardiovascular Magnetic Resonance Imaging for Assessment of Cardiac Thrombus
Goyal, P., & Weinsaft, J. W. (2013) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-9-3-132 · Cited by 44
Fatkin, D., Yeoh, T., Hayward, C., Benson, V. L., Sheu, A., Richmond, Z., Feneley, M. P., KEOGH, A. M., & Macdonald, P. S. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.958918 · Cited by 44
Atrial Dimensions in Health and Left Ventricular Disease Using Cardiovascular Magnetic Resonance
Anderson, J. L., Horne, B. D., & Pennell, D. J. (2005) · Journal of Cardiovascular Magnetic Resonance · doi:10.1081/jcmr-65617 · Cited by 44 · cited 1×
“CMR also allows for accurate and reproducible, noninvasive measurement of the left atrial [5, 6] and right ventricular volume and function [7, 8].”
Left Atrial Volume: Clinical Value Revisited
Tsang, M. Y. C., Barnes, M. E., & Tsang, T. S. M. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0268-8 · Cited by 42
Meluzín, J., Špinarová, L., Hude, P., Krejčí, J., Podroužková, H., Pešl, M., Orban, M., Dušek, L., Jarkovský, J., & Korinek, J. K. (2010) · European Journal of Echocardiography · doi:10.1093/ejechocard/jeq088 · Cited by 42
Abunassar, J. G., Yam, Y., Chen, L., D’Mello, N., & Chow, B. J. W. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.09.040 · Cited by 41
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy
Sinagra, G., Iorio, A., Merlo, M., Cannata, A. N., Stolfo, D., Zambon, E., Nora, C. D., Paolillo, S., Barbati, G., Berton, E., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.232 · Cited by 41
Self-citationKosiuk, J., Nedios, S., Darma, A., Rolf, S., Richter, S., Arya, A., Piorkowski, C., Gaspar, T., Sommer, P., Husser, D., et al. (2014) · EP Europace · doi:10.1093/europace/euu018 · Cited by 40
Kamperidis, V., van Wijngaarden, S. E., van Rosendael, P. J., Kong, W. K. F., Regeer, M. V., van der Kley, F., Sianos, G., Marsan, N. A., Bax, J. J., & Delgado, V. (2017) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jex011 · Cited by 40
Prevalence of resting-ECG abnormalities in systemic lupus erythematosus: a single-center experience
Myung, G., Forbess, L. J., ISHIMORI, M. L., Chugh, S. S., Wallace, D. J., & Weisman, M. H. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3582-0 · Cited by 39
Tigen, K., Karaahmet, T., Kırma, C., Dündar, C., Pala, S., Işıklar, I., Çevik, C., Kılıçgedik, A., & Başaran, Y. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2009.12.022 · Cited by 38
Choi, E., Choi, B. W., Kim, S., Rhee, S. J., Shim, C. Y., Kim, Y. J., Kang, S., Ha, J., & Chung, N. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp050 · Cited by 38
Matsumoto, K., Tanaka, H., Tatsumi, K., Miyoshi, T., Hiraishi, M., Kaneko, A., Tsuji, T., Ryo, K., Fukuda, Y., Yoshida, A., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.11.059 · Cited by 37
Zeng, S., Zhou, Q., Peng, Q., Cao, D., Tian, L., Ao, K., & Liang, X. (2008) · Echocardiography · doi:10.1111/j.1540-8175.2008.00797.x · Cited by 37
Aleksova, A., Merlo, M., Zecchin, M., Sabbadini, G., Barbati, G., Vitrella, G., Lenarda, A. D., & Sinagra, G. (2010) · Clinical Medicine & Research · doi:10.3121/cmr.2010.908 · Cited by 37
Self-citationOral cancer and polymorphism of ethanol metabolising genes
Marichalar‐Mendía, X., Rodriguez-Tojo, M. J., Acha‐Sagredo, A., Rey‐Barja, N., & Urízar, J. M. A. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.09.005 · Cited by 36
Genetics and genetic testing of dilated cardiomyopathy: a new perspective.
Mestroni, L., & Taylor, M. R. G. (2013) · PubMed · Cited by 35
Prophylactic Defibrillator Implantation — Toward an Evidence-Based Approach
Kadish, A. H. (2005) · New England Journal of Medicine · doi:10.1056/nejme048351 · Cited by 35
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy
Losurdo, P., Stolfo, D., Merlo, M., Barbati, G., Gobbo, M., Gigli, M., Ramani, F., Pinamonti, B., Zecchin, M., Finocchiaro, G., et al. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.05.002 · Cited by 35
Self-citationSpartera, M., Damascelli, A., Mózes, F. E., COBELLI, F. D., & Canna, G. L. (2017) · International journal of cardiac imaging · doi:10.1007/s10554-017-1115-1 · Cited by 35
Morimoto, S.-I., Kato, S., Hiramitsu, S., Uemura, A., Ohtsuki, M., Kato, Y., Sugiura, A., Miyagishima, K., Iwase, M., Ito, T., et al. (2003) · Circulation Journal · doi:10.1253/circj.67.490 · Cited by 33 · cited 1×
“Usually hypereosinophilia precedes or coincides with the onset of cardiac symptoms, but the eosinophilia may be delayed [20].”
BackgroundStress-echocardiography in idiopathic dilated cardiomyopathy: instructions for use
Nešković, A., & Otašević, P. (2005) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-3-3 · Cited by 33
Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies
Politano, L. (1996) · JAMA · doi:10.1001/jama.275.17.1335 · Cited by 33
Malaty, A. N., Shah, D. J., Abdelkarim, A. R., & Nagueh, S. F. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.12.017 · Cited by 32
Whole Exome Sequencing Identifies a Troponin T Mutation Hot Spot in Familial Dilated Cardiomyopathy
Campbell, N., Sinagra, G., Jones, K. L., Slavov, D. B., Gowan, K., Merlo, M., Carniel, E., Fain, P. R., Aragona, P., Lenarda, A. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078104 · Cited by 32
Self-citationStreitner, F., Kuschyk, J., Dietrich, C., Mahl, E., Streitner, I., Doesch, C., Veltmann, C., Schimpf, R., Wolpert, C., & Borggrefe, M. (2011) · Clinical Cardiology · doi:10.1002/clc.20949 · Cited by 32
Qin, J. X., Jones, M., Travaglini, A., Song, J., Li, J., White, R. D., Tsujino, H., Greenberg, N. L., Zetts, A. D., Panza, J. A., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.04.012 · Cited by 32
Looi, K., Gajendragadkar, P. R., Khan, F. Z., Elsik, M., Begley, D., Fynn, S. P., Grace, A. A., Heck, P. M., Virdee, M., & Agarwal, S. (2014) · Heart · doi:10.1136/heartjnl-2014-305537 · Cited by 32
Lyme carditis: Persistent local delayed enhancement by cardiac magnetic resonance imaging
Munk, P. S., Ørn, S., & Larsen, A. I. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.05.068 · Cited by 32 · cited 1×
“Cardiac MRI plays a supportive role, typically displaying non-specific epicardial contrast enhancement [17].”
BackgroundWojciechowska, C., Romuk, E. B., Nowalany-Kozielska, E., & Jacheć, W. (2017) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2017.03.006 · Cited by 32
Stolfo, D., Luca, A. D., Morea, G., Merlo, M., Vitrella, G., Caiffa, T., Barbati, G., Rakar, S., Korcova, R., Perkan, A., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.01.009 · Cited by 32
Self-citationArrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy
Stolfo, D., Ceschia, N., Zecchin, M., Luca, A. D., Gobbo, M., Barbati, G., Gigli, M., Masè, M., Pinamonti, B., Pivetta, A., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.02.055 · Cited by 32
Self-citationVenero, J., Doyle, M., Shah, M. B., Rathi, V. K., Yamrozik, J., Williams, R. B., Vido, D. A., Rayarao, G., Benza, R. L., Murali, S., et al. (2015) · ESC Heart Failure · doi:10.1002/ehf2.12041 · Cited by 31
Serdoz, L. V., Daleffe, E., Merlo, M., Zecchin, M., Barbati, G., Pecora, D., Pinamonti, B., Fantoni, C., Lupo, P., Lenarda, A. D., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.02.347 · Cited by 31
Self-citationHu, D.-J., Xu, J., Du, W., Zhang, J., Zhong, M., & Zhou, Y. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-0958-1 · Cited by 31
Effects of enalapril on mortality in severe congestive heart failure
(1988) · Journal of Cardiothoracic Anesthesia · doi:10.1016/0888-6296(88)90169-x · Cited by 31
DNA Analysis in Inherited Cardiomyopathies: Current Status and Clinical Relevance
van Spaendonck‐Zwarts, K. Y., van den Berg, M. P., & van Tintelen, J. P. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.00956.x · Cited by 30 · cited 1×
“According to guidelines, genetic testing is recommended for first-degree relatives when a specific mutation is identified in the proband [4, 11, 13], starting from the age of 10–12, although earlier testing can be considered in laminopathies [11].”
(2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.07.044 · Cited by 30
南條, 修., Yoshikawa, K., Harada, M., Inoue, Y., Namiki, A., Nakano, H., & Yamazaki, J. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0965 · Cited by 29
SANT'ANNA, R. T., Fracasso, J., Valle, F. H., Castro, I., Nardi, N. B., Sant'Anna, J. R. M., Nesralla, I. A., & Kalil, R. A. K. (2014) · Brazilian Journal of Cardiovascular Surgery · doi:10.5935/1678-9741.20140091 · Cited by 29
Ennezat, P. V., Maréchaux, S., Huerre, C., Deklunder, G., Asseman, P., Jude, B., BELLE, E. V., Mouquet, F., Bauters, C., Lamblin, N., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.11.022 · Cited by 29
Clinical management of dilated cardiomyopathy: current knowledge and future perspectives
Merlo, M., Cannata, A. N., Vitagliano, A., Zambon, E., Lardieri, G., & Sinagra, G. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2016.1125292 · Cited by 29
Self-citationCarter, B. A. (2013) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/j.ypat.2012.11.077 · Cited by 29
Stojković, S., Kaider, A., Koller, L., Brekalo, M., Wojta, J., Diedrich, A., Demyanets, S., & Pezawas, T. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13540 · Cited by 29
Aleksova, A., Beltrami, A. P., Carriere, C., Barbati, G., Lesizza, P., Perrieri-Montanino, M., Isola, M., Gentile, P., Salvioni, E., Not, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15349 · Cited by 28
Self-citationPark, S., Choi, B. W., Rim, S., Shim, C. Y., Ko, Y., Kang, S., Ha, J., Jang, Y., Chung, N., Choe, K. O., et al. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.10.003 · Cited by 28
Inherited cardiomyopathies and sports participation
Zorzi, A., Pelliccia, A., & Corrado, D. (2018) · Netherlands Heart Journal · doi:10.1007/s12471-018-1079-3 · Cited by 28
Redefining biomarkers in heart failure
Failure, O. B. O. M. P. S. O. D. D. F. H., Correale, M., Monaco, I., Brunetti, N. D., Biase, M. D., Metra, M., Nodari, S., Butler, J., & Gheorghiade, M. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9683-2 · Cited by 28
Arbustini, E., Pilotto, A., & Repetto, A. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00799-7 · Cited by 28
Iles, L., Pflüger, H., Phrommintikul, A., Cherayath, J., Aksit, P., Gupta, S., Kaye, D. M., & Taylor, A. J. (2008) · Heart Lung and Circulation · doi:10.1016/j.hlc.2008.05.138 · Cited by 27
Cardiac troponin T mutations promote life-threatening arrhythmias
Fiset, C., & Giles, W. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37787 · Cited by 27 · cited 1×
“The same arrhythmic tendency has been shown in carriers of TNNT2 [33], phospholamban (PLN) [34], RNA-binding motif protein 20 (RBM20) [35], TTN [36], and desmosomal mutations.”
Florwick, A., Dharmaraj, T., Jurgens, J. A., Valle, D. L., & Wilson, K. L. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00079 · Cited by 27
Management of Arrhythmias in Heart Failure
Ellison, K., Stevenson, W. G., Sweeney, M. O., Epstein, L. M., & Maisel, W. H. (2003) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2003.00271.x · Cited by 26
Ingle, L., Rigby, A. S., Sloan, R., Carroll, S., Goode, K. M., Cleland, J. G. F., & Clark, A. L. (2014) · Heart · doi:10.1136/heartjnl-2013-304614 · Cited by 26
Cheitlin, M. D. (2006) · Yearbook of Cardiology · doi:10.1016/s0145-4145(07)70191-0 · Cited by 26
Sommerville, R. B., Vincenti, M. G., Winborn, K., Casey, A., Stitziel, N. O., Connolly, A. M., & Mann, D. L. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.06.005 · Cited by 25
Soliman, O. I. I., Theuns, D. A. M. J., ten Cate, F. J., Anwar, A. M., Nemes, A., Vletter, W. B., Jordaens, L. J. L. M., & Geleijnse, M. L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.047 · Cited by 25
Aquila, I., Gonzalez, A. M. M., Fernández‐Golfín, C., Rincon, L. M., Casas, E., García, A., Hinojar, R., Jimenez-Nacher, J. J., & Zamorano, J. L. (2015) · Cardiovascular Ultrasound · doi:10.1186/s12947-016-0061-8 · Cited by 25
Yingchoncharoen, T., Jellis, C. L., Popović, Z., Wang, L., Gai, N., Levy, W. C., Tang, W. H. W., Flamm, S. D., & Kwon, D. H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.095 · Cited by 25
Salerno, G., D’Andrea, A., Bossone, E., Scarafile, R., Riegler, L., Salvo, G. D., Gravino, R., Pezzullo, E., Limongelli, G., Romanò, M., et al. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328349a268 · Cited by 24
Waldo, A. L. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)06008-5 · Cited by 24
Stolfo, D., Stenner, E., Merlo, M., Porto, A. G., Moras, C. B., Barbati, G., Aleksova, A., Buiatti, A., & Sinagra, G. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.06.1205 · Cited by 24
Self-citationRole of Speckle Tracking Echocardiography in Dilated Cardiomyopathy: A Review
Murtaza, G., Virk, H. U. H., Khalid, M. F., Rahman, Z. U., Sitwala, P., Schoondyke, J. W., & Albalbissi, K. (2017) · Cureus · doi:10.7759/cureus.1372 · Cited by 24
Amorim, S., Campelo, M., Moura, B., Martins, E., Rodrigues, J., Barroso, I., Faria, M., Guimarães, J. T., Macedo, F., Silva‐Cardoso, J., et al. (2017) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.02.015 · Cited by 24
Arenja, N., Riffel, J. H., Halder, M., Djiokou, C. N., Fritz, T., André, F., Siepen, F. A. D., Zelniker, T. A., Meder, B., Kayvanpour, E., et al. (2017) · European Radiology · doi:10.1007/s00330-016-4729-0 · Cited by 23
Myocardial Regeneration via Progenitor Cell-Derived Exosomes
Maring, J. A., Beez, C. M., Falk, V., Seifert, M., & Stamm, C. (2017) · Stem Cells International · doi:10.1155/2017/7849851 · Cited by 23
Zhang, Y., Güallar, E., Blasco‐Colmenares, E., Dalal, D., Butcher, B., Norgard, S., Tjong, F. V. Y., ELDADAH, Z. A., Dickfeld, T. L., Ellenbogen, K. A., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.10.034 · Cited by 22
Role of echocardiography to determine candidacy for cardiac resynchronization therapy
Gorcsan, J. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3282f2e260 · Cited by 22
Dini, F. L., Nuti, R., Barsotti, L., Baldini, U., Dell’Anna, R., & Micheli, G. (2002) · Echocardiography · doi:10.1046/j.1540-8175.2002.00457.x · Cited by 22
Mestroni, L., Morgera, T., Miani, D., Pinamonti, B., Sinagra, G., Tanganelli, P., Silvestri, F., & Camerini, F. (1994) · PubMed · Cited by 22
Self-citationVentricular Tachycardia Ablation versus Antiarrhythmic-Drug Escalation
Sapp, J. L., Parkash, R., & Tang, A. S. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1610234 · Cited by 22
D’Andrea, A., Gravino, R., Riegler, L., Salerno, G., Scarafile, R., Romanò, M., Cuomo, S., Viscovo, L. D., Ferrara, I., Rimini, M. L. D., et al. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.11.005 · Cited by 21
Stolfo, D., Tonet, E., Barbati, G., Gigli, M., Pinamonti, B., Zecchin, M., Ramani, F., Merlo, M., & Sinagra, G. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12731 · Cited by 20
Self-citationAquila, I., Fernández‐Golfín, C., Rincon, L. M., Gonzalez, A. M. M., Martín, A. G., Hinojar, R., Nácher, J. J. J., Indolfi, C., & Zamorano, J. L. (2016) · Medicine · doi:10.1097/md.0000000000005387 · Cited by 20
Wells, Q. S., Ausborn, N. L., Funke, B., Pfotenhauer, J. P., Fredi, J. L., Baxter, S., DiSalvo, T. G., & Hong, C. C. (2011) · Cardiogenetics · doi:10.4081/cardiogenetics.2011.e10 · Cited by 19
Inui, K., Tachi, M., Saito, T., Kubota, Y., Murai, K., Kato, K., Takano, H., Amano, Y., Asai, K., & Shimizu, W. (2016) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2016.05.008 · Cited by 19
Genetic bases of dilated cardiomyopathy
Araco, M., Merlo, M., Carr‐White, G., & Sinagra, G. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000432 · Cited by 19
Self-citationRijnierse, M. T., Sadeghian, M., Stekhoven, S. S., Biesbroek, P. S., van der Lingen, A. C. J., van de Ven, P. M., van Rossum, A. C., Nijveldt, R., & Allaart, C. P. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.04.015 · Cited by 19
Nair, N., & Góngora, E. (2018) · Journal of Circulating Biomarkers · doi:10.1177/1849454417751735 · Cited by 19
Brembilla-Perrot, B., Alla, F., Selton‐Suty, C., Huttin, O., Blangy, H., Sadoul, N., Chometon, F., Groben, L., Luporsi, J. D., ZANNAD, N., et al. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.01199.x · Cited by 18
Mu, Y., Lu, C., Tang, Q., & Ayoufu, G. (2010) · Echocardiography · doi:10.1111/j.1540-8175.2009.01028.x · Cited by 18
Sveric, K. M., Ulbrich, S., Rady, M., Ruf, T. F., Kvakan, H., Strasser, R. H., & Jellinghaus, S. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-0965 · Cited by 18
Merlo, M., Masè, M., Vitrella, G., Belgrano, M., Faganello, G., Giusto, F. D., Boscutti, A., Gobbo, M., Gigli, M., Altinier, A., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.04.017 · Cited by 18
Self-citationHsia, H. H., Callans, D. J., & Marchlinski, F. E. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.10.023 · Cited by 18
Grimm, W., Christ, M., Bach, J., Muller, H. H., & Maisch, B. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.03.039 · Cited by 18
(2000) · Time to knit · doi:10.1016/j.ymed.2016.08.087 · Cited by 18
Left atrial deformation and nonischemic dilated cardiomyopathy: A 2D speckle-tracking imaging study
Güler, A., Tigen, K. M., Dündar, C., Karaahmet, T., Karabay, C. Y., Aung, S. M., Akgün, T., Bulut, M., & Kırma, C. (2013) · Herz · doi:10.1007/s00059-013-3817-z · Cited by 17
Advanced Imaging of Cardiac Sarcoidosis
Ayoub, C., Peña, E., Ohira, H., DICK, A. J., Leung, E., Nery, P. B., Birnie, D. H., & Beanlands, R. S. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0572-1 · Cited by 17
Zecchin, M., Lenarda, A. D., Bonin, M., Mazzone, C., Zanchi, C., Chiara, C. D., D'Avanzo, M., Scherl, G., Sabbadini, G., & Sinagra, G. (2001) · PubMed · Cited by 17
Self-citationTanaka, K., 伊藤, 正., Kodama, M., Maruyama, H., Hoyano, M., Mitsuma, W., Iino, N., Hirono, S., Okura, Y., Gejyo, F., et al. (2007) · Circulation Journal · doi:10.1253/circj.71.1927 · Cited by 16 · cited 1×
“In idiopathic DCM, renal failure occurs in 20% of patients during the first 8 years after diagnosis, up to 50% at 20-year follow-up [59].”
BackgroundGalrinho, A., Branco, L. M., Soares, R. M., Miranda, F., Leal, A., & Ferreira, R. C. (2009) · PubMed · Cited by 16
Sousa, P. A., Bettencourt, N., Ferreira, N. D., Carvalho, M., Leite, D., Ferreira, W., de Jesus, I., & Gama, V. (2014) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2014.02.028 · Cited by 16
Moon, J., Shim, C. Y., Kim, Y. J., Park, S., Kang, S., Chung, N., & Ha, J. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.12.011 · Cited by 16
Early Right Ventricular Response To Cardiac Resynchronization Therapy: Impact on Clinical Outcomes
Stolfo, D., Tonet, E., Merlo, M., Barbati, G., Gigli, M., Pinamonti, B., Ramani, F., Zecchin, M., & Sinagra, G. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.450 · Cited by 16
Self-citationBobbo, M., Pinamonti, B., Merlo, M., Stolfo, D., Iorio, A., Ramani, F., Barbati, G., Carriere, C., Massa, L., Poli, S., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.10.014 · Cited by 16
Self-citationCardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations
Sanna, T., Russo, A. D., & Toniolo, D. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.03.044 · Cited by 14 · cited 1×
“The overt phase of systolic dysfunction is usually associated with LV dilatation, but this may be absent in some cases causing diagnostic confusion (described in Lamin A/C gene mutation carriers [4, 5] and also in some patients without a known genetic cause [6–8] (Fig.”
Cheitlin, M. D. (2010) · Yearbook of Cardiology · doi:10.1016/s0145-4145(10)79855-5 · Cited by 14
Iles, L., Pflüger, H., Lefkovits, L., Butler, M. J., Kistler, P. M., Kaye, D. M., & Taylor, A. J. (2010) · Heart Lung and Circulation · doi:10.1016/j.hlc.2010.06.845 · Cited by 13
Bh, M., & Putman, C. E. (1985) · PubMed · Cited by 13
Muser, D., Mendelson, T. B., Fahed, J., Liang, J. J., Castro, S. A., Zado, E. S., Marchlinski, F. E., & Santangeli, P. (2017) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13149 · Cited by 13
Current status of cell therapy for non-ischaemic cardiomyopathy: a brief overview: Table 1
Bolli, R., & Ghafghazi, S. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv454 · Cited by 12
The MOGE(S) classification: A TNM-like classification for cardiomyopathies
Şahan, E., Şahan, S., Karamanlıoğlu, M., Gul, M., & Tüfekçioğlu, O. (2016) · Herz · doi:10.1007/s00059-015-4394-0 · Cited by 12
Merlo, M., Anzini, M., Bussani, R., Artico, J., Barbati, G., Stolfo, D., Gigli, M., Muça, M., Naso, P., Ramani, F., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.05.063 · Cited by 12
Self-citationPogwizd, S. M., McKenzie, J. P., & CAIN, M. E. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)80285-3 · Cited by 12
Novel biomarkers and therapies in cardiorenal syndrome
Latini, R., Aleksova, A., & Masson, S. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.01.010 · Cited by 11
The natural history of dilated cardiomyopathy
Merlo, M., Gentile, P., Naso, P., & Sinagra, G. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000459 · Cited by 11
Self-citation[Cardiomyopathy in Italy today: extent of the problem].
Dolara, A., Cecchi, F., & Ciaccheri, M. (1989) · PubMed · Cited by 10
Soriano, C. J., Ridocci, F., Estornell, J., Jimenez, J., Martinez, V., & DEVELASCO, J. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.06.035 · Cited by 10
Prognostic implications of tissue Doppler in patients with dilated cardiomyopathy.
Galrinho, A., Branco, L. M., Soares, R. M., Timóteo, A. T., Abreu, J., Leal, A., Silva, S., & Ferreira, R. C. (2006) · PubMed · Cited by 9
Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy
Graham, T. P. (2006) · Yearbook of Cardiology · doi:10.1016/s0145-4145(07)70092-8 · Cited by 9
1212Gene-based risk stratification for cardiac disorders in LMNA mutation carriers
Nishiuchi, S., Makiyama, T., Aiba, T., Nakajima, K., Watanabe, H., Ohno, S., Minamino, T., Saito, Y., Nogami, A., Aonuma, K., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx502.1212 · Cited by 9
Aleksova, A., Barbati, G., Merlo, M., Stolfo, D., Sabbadini, G., Lenarda, A. D., & Sinagra, G. (2010) · Heart & Lung · doi:10.1016/j.hrtlng.2010.06.001 · Cited by 8
Self-citationOhshima, K., Hirashiki, A., Cheng, X. W., Hayashi, M., Hayashi, D., Okumura, T., Sakakibara, M., Funahashi, H., Ohshima, S., & Murohara, T. (2011) · International Heart Journal · doi:10.1536/ihj.52.366 · Cited by 8
Sekiguchi, M., Hasegawa, A., Hiroe, M., Morimoto, S., & Nishikawa, T. (2008) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.02.001 · Cited by 6
Complexities of Genetic Testing in Familial Dilated Cardiomyopathy
Wolf, M. J., Noeth, D., Rammohan, C., & Shah, S. H. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.115.001157 · Cited by 6
Fayssoil, A. (2010) · PubMed · Cited by 5
Piers, S. R. D., Leong, D. P., van Taxis, C. F. B. V. H., Tayyebi, M., Trines, S. A., Pijnappels, D. A., Delgado, V., Schalij, M. J., & Zeppenfeld, K. (2013) · Leiden Repository (Leiden University) · Cited by 5
Natriuretic Peptides and Biomarkers in the Diagnosis of Heart Failure
Phreaner, N., Shah, K., & Maisel, A. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-15961-4_12 · Cited by 4
Sousa, P. A., Bettencourt, N., Ferreira, N. D., Carvalho, M., Leite, D., Ferreira, W., de Jesus, I., & Gama, V. (2014) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2014.02.025 · Cited by 4
[Changes in medical treatment of heart failure in the light of large clinical trials].
Sinagra, G., Sabbadini, G., Lenarda, A. D., Gortan, R., Massa, L., Carniel, E., & Driussi, M. (2001) · PubMed · Cited by 3
Self-citationBasic Echocardiography in Hypertrophic Cardiomyopathy
Finocchiaro, G., Pinamonti, B., & Abate, E. (2014) · Springer eBooks · doi:10.1007/978-3-319-06019-4_10 · Cited by 3
Self-citationCheitlin, M. D. (2007) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)70197-7 · Cited by 3
Role of Cardiac Imaging: Cardiac Magnetic Resonance and Cardiac Computed Tomography
Vitrella, G., Faganello, G., Morea, G., Pagnan, L., Belgrano, M., & Cova, M. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-13864-6_8 · Cited by 3
Research works printed but not linked: 77
- [426]Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation. 2010;122:900-9.
- [428]Chimenti C, Frustaci A. Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period. Circulation. 2013;128:1531-41.
- [435]Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;128(16):e240-327.
- [437]Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Wojciechowska C, Glanowska G, Wilczewski P, et al. Randomized, placebo-controlled study for immunosuppressive treat- ment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation. 2001;104(1):39-45.
- [447]Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006;113:876-90.
- [448]Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al. Update on myocar- ditis. J Am Coll Cardiol. 2012;59:779-92.
- [454]Towbin JA, Lorts A. Arrhythmias and dilated cardiomyopathy common pathogenetic path- ways? J Am Coll Cardiol. 2011;57(21):2169-71.
- [478]Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221-30.
- [482]Goldberger JJ, Subačius H, Patel T, Cunnane R, Kadish AH. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2014;63(18):1879-89.
- [484]Arbustini E, Disertori M, Narula J. Primary prevention of sudden arrhythmic death in dilated cardiomyopathy current guidelines and risk stratification. JACC Heart Fail. 2017;5(1):39-43.
- [486]van Rijsingen IA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF, van der Kooi AJ, et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59(5):493-500.
- [487]Phillips E, Levine SA. Auricular fibrillation without other evidence of heart disease; a cause of reversible heart failure. Am J Med. 1949;7(4):478-89.
- [488]Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol. 1996;19(1):95-106.
- [489]Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management. J Am Coll Cardiol. 2015;66(15):1714-28.
- [493]Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133(17):1637-44.
- [494]Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358(25):2667-77.
- [497]Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006;48(11):2340-7.
- [498]Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118(24):2498-505.
- [500]Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417-27.
- [504]Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation. 2009;120(22):2170-6.
- [506]Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta- blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA. 2006;295(2):165-71.
- [516]Nakahara S, Tung R, Ramirez RJ, Michowitz Y, Vaseghi M, Buch E, et al. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol. 2010;55(21):2355-65.
- [521]Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy. Circulation. 2014;129:728-36.
- [522]Oloriz T, Silberbauer J, Maccabelli G, Mizuno H, Baratto F, Kirubakaran S, et al. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus infero- lateral scar sub-types. Circ Arrhythm Electrophysiol. 2014;7(3):414-23.
- [523]Dinov B, Arya A, Schratter A, Schirripa V, Fiedler L, Sommer P, et al. Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality? Circ Arrhythm Electrophysiol. 2015;8(3):598-605.
- [524]Yu R, Ma S, Tung R, Stevens S, Macias C, Bradfield J, et al. Catheter ablation of scar-based ventricular tachycardia: relationship of procedure duration to outcomes and hospital mortality. Heart Rhythm. 2015;12(1):86-94.
- [525]Gökoğlan Y, Mohanty S, Gianni C, Santangeli P, Trivedi C, Güneş MF, et al. Scar homog- enization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol. 2016;68(18):1990-8.
- [526]Santangeli P, Muser D, Zado ES, Magnani S, Khetpal S, Hutchinson MD, et al. Acute hemo- dynamic decompensation during catheter ablation of scar-related ventricular tachycardia: inci- dence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol. 2015;8(1):68-75.
- [527]Muser D, Liang JJ, Castro SA, Hayashi T, Enriquez A, Troutman GS, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergo- ing catheter ablation of scar-related ventricular tachycardia: a propensity-matched analysis. Heart Rhythm. 2018;15(10):1500-6.
- [529]Piers SR, Tao Q, van Huls van Taxis CF, Schalij MJ, van der Geest RJ, Zeppenfeld K. Contrast- enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonisch- emic cardiomyopathy: implications for the ablation strategy. Circ Arrhythm Electrophysiol. 2013;6(5):875-83.
- [530]Hayashi T, Santangeli P, Pathak RK, Muser D, Liang JJ, Castro SA, et al. Outcomes of catheter ablation of idiopathic outflow tract ventricular arrhythmias with an R wave pattern break in lead V2: a distinct clinical entity. J Cardiovasc Electrophysiol. 2017;28(5):504-14.
- [531]Berruezo A, Mont L, Nava S, Chueca E, Bartholomay E, Brugada J. Electrocardiographic rec- ognition of the epicardial origin of ventricular tachycardias. Circulation. 2004;109(15):1842-7.
- [532]Shun-Shin MJ, Zheng SL, Cole GD, Howard JP, Whinnett ZI, Francis DP. Implantable car- dioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials. Eur Heart J. 2017;38(22):1738-46.
- [571]Merlo M, Pyxaras SA, Pinamonti B, Barbati G, Di Lenarda A, Sinagra G. Prevalence and prog- nostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol. 2011;57:1468-76. https://doi.org/10.1016/j. jacc.2010.11.030. · doi:10.1016/j
- [604]Sinagra G, Anzini M, Pereira NL, Bussani R, Finocchiaro G, Bartunek J, et al. Myocarditis in clinical practice. Mayo Clin Proc. 2016;91(9):1256-66. https://doi.org/10.1016/j. mayocp.2016.05.013. · doi:10.1016/j
- [653]Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. JAMA. 1996;276(3):199.
- [658]Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115(12):1643-455.
- [667]Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guide- lines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. https://doi.org/10.1093/eurheartj/ ehw128. · doi:10.1093/eurheartj/
- [677]McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin- neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993-1004. https://doi.org/10.1056/NEJMoa1409077. · DOI · Paper page
- [687]Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defi- brillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-8.
- [689]Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E, et al. Defibrillator implanta- tion in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221-30. https://doi.org/10.1056/NEJMoa1608029. · DOI · Paper page
- [692]Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. Department of Veterans Affairs Survival Trial of antiarrhythmic therapy in congestive heart failure. QRS duration and mortal- ity in patients with congestive heart failure. Am Heart J. 2002;143(6):1085-91.
- [706]Stolfo D, Merlo M, Pinamonti B, Poli S, Gigli M, Barbati G, et al. Early improvement of func- tional mitral regurgitation in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2015;115(8):1137-43. https://doi.org/10.1016/j.amjcard.2015.01.549. · DOI
- [718]Merlo M, Anzini M, Bussani R, Artico J, Barbati G, Stolfo D, et al. Characterization and long- term prognosis of postmyocarditic dilated cardiomyopathy compared with idiopathic dilated cardiomyopathy. Am J Cardiol. 2016;118:895-900.
- [726]Priori SG, Blomström-Lundqvist C, Mazzanti A. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;8:746-837.
- [728]Dal Ferro M, Stolfo D, Altinier A, Gigli M, Perrieri M, Ramani F, et al. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy. Heart. 2017;103:1704-10.
- [735]Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10:531-47.
- [736]Menon SC, Michels VV, Pellikka PA, Ballew JD, Karst ML, Herron KJ, et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. Clin Genet. 2008;74:445-54.
- [737]Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK. Personalizing risk stratification for sud- den death in dilated cardiomyopathy. Circulation. 2017;136:215-31.
- [740]Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycar- dia-AMIOVIRT. J Am Coll Cardiol. 2003;41:1707-12.
- [741]Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defibril- lator implantation in patients with nonischemic dilated cardiomyopathy for the defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE) investigators. N Engl J Med. 2004;350:2151-8.
- [742]Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implant- able cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37.
- [743]Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221-30.
- [745]Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JGF, et al. Prediction of mode of death in heart failure: the Seattle heart failure model. Circulation. 2007;116:392-8.
- [747]Spezzacatene A, Sinagra G, Merlo M, Barbati G, Graw SL, Brun F, et al. Arrhythmogenic phe- notype in dilated cardiomyopathy: natural history and predictors of life-threatening arrhyth- mias. J Am Heart Assoc. 2015;4:e002149.
- [750]Van Rijsingen IAW, Van Der Zwaag PA, Groeneweg JA, Nannenberg EA, Jongbloed JDH, Zwinderman AH, et al. Outcome in phospholamban R14del carriers results of a large multi- centre cohort study. Circ Cardiovasc Genet. 2014;7:455-65.
- [754]Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309:896-908.
- [755]Di Marco A, Anguera I, Schmitt M, Klem I, Neilan T, White JA, et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopa- thy: systematic review and meta-analysis. JACC Heart Fail. 2017;5:28-38.
- [758]Merlo M, Gobbo M, Stolfo D, Losurdo P, Ramani F, Barbati G, et al. The prognostic impact of the evolution of RV function in idiopathic DCM. JACC Cardiovasc Imaging. 2016;9:1034-42.
- [760]Goldberger JJ, Subačius H, Patel T, Cunnane R, Kadish AH. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2014;63:1879-89.
- [761]Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, et al. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?". Am J Cardiol. 2012;109:729-35.
- [762]Losurdo P, Stolfo D, Merlo M, Barbati G, Gobbo M, Gigli M, et al. Early arrhythmic events in idiopathic dilated cardiomyopathy. JACC Clin Electrophysiol. 2016;2:535-43.
- [763]Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, et al. Use of the wear- able cardioverter defibrillator in high-risk cardiac patients data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II registry). Circulation. 2015;132:1613-9.
- [765]Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail. 2014;16:317-24.
- [766]McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin- neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993-1004.
- [768]Hare JM, DiFede DL, Castellanos AM, Florea V, Landin AM, El-Khorazaty J, et al. Randomized comparison of allogeneic vs. autologous mesenchymal stem cells for non-ischemic dilated car- diomyopathy: POSEIDON-DCM trial. J Am Coll Cardiol. 2017;69:526-37.
- [769]Woitek F, Zentilin L, Hoffman NE, Powers JC, Ottiger I, Parikh S, et al. Intracoronary cyto- protective gene therapy: a study of VEGF-B167 in a pre-clinical animal model of dilated car- diomyopathy. J Am Coll Cardiol. 2015;66:139-53.
- [771]Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67:2996-3010.
- [775]Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305-24.
- [781]Pérez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391:82-94.
- [783]de Andrade JP, Marin Neto JA, de Paola AAV, Vilas-Boas F, Oliveira GMM, Bacal F, et al. I Latin American guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol. 2011;96:434-42.
- [784]Rassi A, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease. Circulation. 2007;115:1101-9.
- [785]Fish AE, Pride YB, Pinto DS. Lyme carditis. Infect Dis Clin North Am. 2008;22:275-88.
- [800]Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopa- thy. N Engl J Med. 2000;342:1077-84.
- [801]Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 European Society of Cardiology position paper on cancer treatments and cardiovas- cular toxicity. Eur Heart J. 2016;37:2768-801.
- [804]Ware JS, Amor-salamanca A, Tayal U, Govind R, Serrano I, Pascual-figal DA, et al. Genetic etiology for alcohol-induced cardiac toxicity. J Am Coll Cardiol. 2018;71:2293-302.
- [811]Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic cardio- myopathy. World J Cardiol. 2014;6:771-81.
Cited by
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments
Orphanou, N., Papatheodorou, E., & Anastasakis, A. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10139-0 · Cited by 137
Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity
Cullen, M. R., Lemeshow, A. R., Russo, L., Barnes, D. M., Ababio, Y., & Habtezion, A. (2022) · Healthcare · doi:10.3390/healthcare10040603 · Cited by 59
Inherited Arrhythmias in the Pediatric Population: An Updated Overview
Mariani, M. V., Pierucci, N., Fanisio, F., Laviola, D., Silvetti, G., Piro, A., Fazia, V. M. L., Chimenti, C., Rebecchi, M., Drago, F., et al. (2024) · Medicina · doi:10.3390/medicina60010094 · Cited by 46
“VA is infrequently found to be the root of HF in children [110].”
BackgroundRisk stratification in cardiomyopathy
Sinagra, G., Carriere, C., Clemenza, F., Minà, C., Bandera, F., Zaffalon, D., Gugliandolo, P., Merlo, M., Guazzi, M., & Agostoni, P. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320961898 · Cited by 37
Self-citationDilated cardiomyopathy: a new insight into the rare but common cause of heart failure
Giri, P., Mukhopadhyay, A., Gupta, M., & Mohapatra, B. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10125-6 · Cited by 33
Metadata
- Authors
- Sinagra, G., Merlo, M., & Pinamonti, B.
- Affiliations
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
- ORCID
- Gianfranco Sinagra
- Venue
- Springer eBooks
- Publisher
- Springer International Publishing
- Published
- 2019
- OpenAlex
- W4313642785
- Cited by
- 32
- References
- 603
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 9 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 2
- FWCI
- 5.48
- Type
- book
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Springer eBooks (publishedVersion, cc-by)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
- Directory of Open access Books (OAPEN Foundation) (submittedVersion, cc-by)
- Funders
- ACRC - Associazione Culturale per la Ricerca in Cardioscienze
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- dilated cardiomyopathy, pathophysiology, differential diagnosis, clinical management, genetic testing, cardiac arrhythmias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.